Development of Novel Symptom Score to Assist in Screening for Exocrine Pancreatic Insufficiency

Overview of attention for article published in Epidemiologia, August 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 3 X users

bluesky: 2 Bluesky users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 15,635 followers.

RT @danamlewis: @UGrewalMD Seems common outside of oncology, too. We are doing a study in NZ right now to see if the EPI/PEI-SS (https://t.…

@UGrewalMD Seems common outside of oncology, too. We are doing a study in NZ right now to see if the EPI/PEI-SS (https://t.co/O8Rp37Bekl) is useful in a pancreatic cancer population (comparing with elastase) for screening for EPI, using frequency x seve…

You can read the full research paper here: https://t.co/O8Rp37Bekl Or, read my summary and highlights from the paper here: https://t.co/uyUHdsEjPK Let me know what questions you have! (6/6)

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.